ストックスクリーナーアプリを入手
0.00
100.00%
-14.84
前日終値:
$14.84
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$2.20B
収益：
-
当期純損益:
$-174.61M
株価収益率:
0.00
EPS:
-1.97
ネットキャッシュフロー:
$-165.54M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$15.06
89 Bio Inc Stock (ETNB) Company Profile
ETNB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
0.00 | 2.20B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-04 | 再開されました | H.C. Wainwright | Buy |
| 2025-03-14 | 開始されました | Goldman | Neutral |
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2024-04-22 | 再開されました | BofA Securities | Buy |
| 2024-01-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-08-28 | 開始されました | UBS | Buy |
| 2023-06-13 | 開始されました | Evercore ISI | Outperform |
| 2022-05-12 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-26 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-07-29 | 再開されました | BTIG Research | Buy |
| 2021-05-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-19 | 開始されました | Raymond James | Strong Buy |
| 2020-09-25 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-07-31 | 開始されました | Piper Sandler | Overweight |
| 2020-07-23 | 開始されました | BTIG Research | Buy |
| 2020-07-07 | 開始されました | Chardan Capital Markets | Buy |
| 2019-12-09 | 開始されました | BofA/Merrill | Neutral |
| 2019-12-09 | 開始されました | Oppenheimer | Outperform |
| 2019-12-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2019-12-09 | 開始されました | SVB Leerink | Outperform |
すべてを表示
89 Bio Inc (ETNB) 最新ニュース
Is 89bio Inc. stock supported by innovation pipelineEarnings Risk Report & Reliable Trade Execution Plans - ulpravda.ru
How 89bio Inc. stock compares to market leadersMarket Sentiment Report & Verified Momentum Stock Ideas - ulpravda.ru
Is 89bio Inc. stock attractive for ETFsTake Profit & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is 89bio Inc. stock dividend yield sustainableWeekly Risk Report & Verified Momentum Watchlists - ulpravda.ru
How 89bio Inc. stock compares to growth peers2025 Key Highlights & AI Powered Market Trend Analysis - Улправда
Aug Sectors: Is 89bio Inc. stock dividend yield sustainableWeekly Trade Report & Expert Curated Trade Setup Alerts - Улправда
Will 89bio Inc. stock recover faster than peersJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - Улправда
Downgrade Watch: How 89bio Inc. stock compares to growth peers2025 Macro Impact & Daily Risk Controlled Trade Plans - Улправда
[EFFECT] 89bio, Inc. SEC Filing - Stock Titan
89bio Acquisition Finalized: Roche Completes Takeover () - aktiencheck.de
[Form 4] 89bio, Inc. Insider Trading Activity - Stock Titan
Fatty liver disease companies' multibillion-dollar deals mean fatter wallets - The Business Journals
ETNB CEO Form 4 details Roche deal payout and option treatment - Stock Titan
ETNB officer reports tender offer completion; shares exchanged for $14.50 + CVR - Stock Titan
[POSASR] 89bio, Inc. SEC Filing - Stock Titan
Roche Holdings completes acquisition of 89bio and delists company from Nasdaq - Investing.com
Roche completes 89bio deal; ETNB holders get $14.50 cash + CVR - Stock Titan
89bio acquired by Roche with $14.50 cash and up to $6 CVR - Stock Titan
Roche purchases shares in tender offer for 89bio, Inc - The Manila Times
Roche (OTCQX: RHHBY) accepts 60.49% of 89bio shares, plans merger at $14.50 + CVR - Stock Titan
89bio, Inc.(NasdaqGM: ETNB) dropped from S&P Biotechnology Select Industry Index - MarketScreener
Roche Holding AG completed the acquisition of 89bio, Inc. in a tender offer transaction. - MarketScreener
ETNB CFO option exercises update direct holdings to 339,295 shares - Stock Titan
[SC TO-T/A] 89bio, Inc. Amended Third-Party Tender Offer | ETNB SEC FilingForm SC TO-T/A - Stock Titan
Will 89bio Inc. stock split attract more investorsTrade Analysis Report & Safe Entry Zone Tips - Trung tâm Dự báo KTTV quốc gia
How strong is 89bio Inc. stock balance sheetEarnings Risk Summary & Fast Moving Stock Watchlists - Trung tâm Dự báo KTTV quốc gia
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (NasdaqETNB), Barinthus Biotherapeutics plc (NasdaqBRNS), Verint Systems Inc. (Nasdaq - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Combining price and volume data for 89bio Inc.Layoff News & Long-Term Growth Stock Strategies - newser.com
Will 89bio Inc. stock benefit from AI adoption2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
89bio, Inc. (ETNB) Stock Analysis: Unveiling A 97% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
Janus Henderson Reports 5,378,185 Shares, 3.6% Stake in 89bio - Stock Titan
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Investors Purchase High Volume of Put Options on 89BIO (NASDAQ:ETNB) - Defense World
After courting 14 pharmas, 89bio was left between a Roche and hard place in buyout talks - Fierce Biotech
Roche commences tender offer for all shares of 89bio, Inc. - GlobeNewswire
$20.50 Per Share Deal: Roche Makes Move to Acquire 89bio in Major Biotech Tender Offer - Stock Titan
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal - MSN
Roche Initiates Tender Offer for 89bio (ETNB) in $3.5B Acquisiti - GuruFocus
Kala Bio Stock Just Plunged 89% Today – Here’s What Happened - Stocktwits
Why 89bio Inc. stock is rated strong buy2025 Biggest Moves & Verified Entry Point Detection - newser.com
Technical analysis overview for 89bio Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is 89bio Inc. stock attractive for retirement portfoliosWeekly Stock Report & Momentum Based Trading Ideas - newser.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders - GlobeNewswire Inc.
Backtesting results for 89bio Inc. trading strategiesQuarterly Trade Review & Short-Term High Return Strategies - newser.com
How 89bio Inc. stock reacts to global recession fearsBear Alert & Community Consensus Picks - newser.com
Measuring 89bio Inc.’s beta against major indicesEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com
89bio, Inc. Hits New 52-Week High of $15.06, Up 76.62% - Markets Mojo
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB) - PR Newswire
How to integrate 89bio Inc. into portfolio analysis toolsJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
89 Bio Inc (ETNB) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):